Hofseth BioCare Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Hofseth BioCare zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | -8.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Here's Why Hofseth BioCare (OB:HBC) Can Afford Some Debt
Apr 01We Think Hofseth BioCare (OB:HBC) Has A Fair Chunk Of Debt
Dec 22Health Check: How Prudently Does Hofseth BioCare (OB:HBC) Use Debt?
Apr 28Hofseth BioCare (OB:HBC) Is Carrying A Fair Bit Of Debt
Oct 16Is Hofseth BioCare (OB:HBC) Using Debt Sensibly?
Feb 24How Much Of Hofseth BioCare ASA (OB:HBC) Do Insiders Own?
Jan 28Are Insiders Buying Hofseth BioCare ASA (OB:HBC) Stock?
Dec 25Hofseth BioCare (OB:HBC) Shareholders Have Enjoyed A Whopping 339% Share Price Gain
Nov 20In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hofseth BioCare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 219 | -107 | -33 | -10 | N/A |
9/30/2023 | 205 | -93 | 43 | 61 | N/A |
6/30/2023 | 185 | -105 | -6 | 11 | N/A |
3/31/2023 | 134 | -140 | -54 | -36 | N/A |
12/31/2022 | 120 | -137 | -63 | -45 | N/A |
9/30/2022 | 113 | -136 | -133 | -114 | N/A |
6/30/2022 | 96 | -139 | -110 | -90 | N/A |
3/31/2022 | 102 | -135 | -84 | -53 | N/A |
12/31/2021 | 88 | -126 | -100 | -62 | N/A |
9/30/2021 | 85 | -120 | -103 | -59 | N/A |
6/30/2021 | 79 | -115 | -100 | -43 | N/A |
3/31/2021 | 68 | -111 | -114 | -56 | N/A |
12/31/2020 | 69 | -102 | -116 | -62 | N/A |
9/30/2020 | 57 | -104 | -103 | -54 | N/A |
6/30/2020 | 79 | -90 | -99 | -63 | N/A |
3/31/2020 | 72 | -86 | -73 | -49 | N/A |
12/31/2019 | 68 | -89 | -51 | -31 | N/A |
9/30/2019 | 71 | -79 | 19 | 25 | N/A |
6/30/2019 | 59 | -81 | -36 | -36 | N/A |
3/31/2019 | 61 | -83 | -31 | -23 | N/A |
12/31/2018 | 61 | -85 | -38 | -29 | N/A |
9/30/2018 | 73 | -74 | -104 | -81 | N/A |
6/30/2018 | 84 | -66 | -28 | -3 | N/A |
3/31/2018 | 75 | -66 | -36 | -20 | N/A |
12/31/2017 | 66 | -16 | -39 | -25 | N/A |
9/30/2017 | 43 | -28 | N/A | -18 | N/A |
6/30/2017 | 19 | -60 | N/A | -43 | N/A |
3/31/2017 | 21 | -92 | N/A | -70 | N/A |
12/31/2016 | 20 | -147 | N/A | -67 | N/A |
9/30/2016 | 21 | -165 | N/A | -8 | N/A |
6/30/2016 | 34 | -137 | N/A | -2 | N/A |
3/31/2016 | 32 | -109 | N/A | 1 | N/A |
12/31/2015 | 32 | -100 | N/A | 8 | N/A |
9/30/2015 | 38 | -84 | N/A | -54 | N/A |
6/30/2015 | 23 | -82 | N/A | -47 | N/A |
3/31/2015 | 24 | -72 | N/A | -72 | N/A |
12/31/2014 | 20 | -67 | N/A | -61 | N/A |
9/30/2014 | 39 | -40 | N/A | -70 | N/A |
6/30/2014 | 62 | -35 | N/A | -103 | N/A |
3/31/2014 | 63 | -39 | N/A | -58 | N/A |
12/31/2013 | 63 | -52 | N/A | -77 | N/A |
9/30/2013 | 41 | -98 | N/A | -81 | N/A |
6/30/2013 | 27 | -96 | N/A | -55 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von HBC über der Sparquote liegt (2%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von HBC schneller wachsen werden als der Markt Norwegian
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von HBC in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von HBC schneller wachsen werden als der Markt von Norwegian.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von HBC schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von HBC in 3 Jahren voraussichtlich hoch sein wird